Lavipharm (FRA:BXA0) Marketable Securities : €0.00 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Lavipharm Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Lavipharm's Marketable Securities for the quarter that ended in Jun. 2024 was €0.00 Mil.

Lavipharm's annual Marketable Securities increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.00 Mil) and increased from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€0.00 Mil).

Lavipharm Marketable Securities Historical Data

The historical data trend for Lavipharm's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lavipharm Marketable Securities Chart

Lavipharm Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

Lavipharm Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Marketable Securities	Get a 7-Day Free Trial						-	-	1.97	-	-

Lavipharm Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Lavipharm (FRA:BXA0) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Lavipharm Marketable Securities Related Terms

Thank you for viewing the detailed overview of Lavipharm's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Lavipharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (FRA:BXA0) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

LAVI:Greece

Address

Agias Marinas Street, PO Box 59, Peania Attica, GRC, 19002

Website

http://www.lavipharm.com

Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Lavipharm Headlines

No Headlines